# Propolis Skin Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/propolis-skin-meta-analysis-evidence-review
Category: evidence-review
Summary: Propolis Skin Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic 
Last reviewed: 2026-07-29
Reviewed by: Migaku Evidence Review
# Propolis Skin Meta-analysis: What the Evidence Says

## Quick Answer

Propolis Skin Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 systematic review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Evidence and Clinical Applications of Natural Products in Veterinary Medicine: A Systematic Review of Clinoptilolite, Ozone Therapy, Propolis, and Phytotherapy | systematic review | 1 | 2026-05-16 | 10.3390/vetsci13050483 |
| Propolis Supplementation and Metabolic Syndrome Components in Adults at Risk: A Systematic Review and Meta&#8208;Analysis of Randomized Controlled Trials | systematic review | 1 | 2026-02-25 | 10.1002/hsr2.71909 |

## What The Sources Report

- These effects contribute not only to improved productivity but also to better animal welfare, illustrating the potential of CPL as a safe and sustainable feed additive in modern veterinary practice. [&#272;uri&#269;i&#263; Dra&#382;en (2026); evidence level 1]
- Its unique physicochemical properties, combined with its demonstrated clinical benefits, make it an important tool for enhancing animal health and productivity in an evidence-based framework. [&#272;uri&#269;i&#263; Dra&#382;en (2026); evidence level 1]
- These factors collectively increase the risk of developing noncommunicable diseases such as cardiovascular disease (CVD), type 2 diabetes mellitus (T2DM), nonalcoholic fatty liver disease (NAFLD), chronic kidney disease (CKD), and overall mortality. [Rab Safia Obaidur (2026); evidence level 1]
- Consequently, this systematic review and meta-analysis aimed to assess the specific effects of propolis supplementation on components of MetS in adults at risk. [Rab Safia Obaidur (2026); evidence level 1]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For propolis skin meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- &#272;uri&#269;i&#263; Dra&#382;en (2026). Evidence and Clinical Applications of Natural Products in Veterinary Medicine: A Systematic Review of Clinoptilolite, Ozone Therapy, Propolis, and Phytotherapy. DOI: 10.3390/vetsci13050483. PMCID: PMC13211563. PMID: 42188953. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13211563/
- Rab Safia Obaidur (2026). Propolis Supplementation and Metabolic Syndrome Components in Adults at Risk: A Systematic Review and Meta&#8208;Analysis of Randomized Controlled Trials. DOI: 10.1002/hsr2.71909. PMCID: PMC12935762. PMID: 41767366. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open .... https://pmc.ncbi.nlm.nih.gov/articles/PMC12935762/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.